CD274 and non-small cell lung carcinoma: Thepositive outcomes between PD-L1 rs2890658 polymorphism and NSCLC risk by allele contrast (OR: 1.53, 95%CI=1.09-2.13, P = 0.013) is shown in Figure 2, heterozygous comparison (OR: 1.50, 95%CI = 1.04–2.16, P = 0.030) is shown in Figure 3, and dominate genetic model (OR: 1.54, 95%CI = 1.07–2.21, P = 0.019) is shown in Figure 4.